Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
6
6 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- SKY-0515Phase 33 trials
Skyhawk Therapeutics, Inc. · Huntington Disease, Huntingtons Disease, Huntington's Disease (HD)
- PridopidinePhase 32 trials
Prilenia · Amyotrophic Lateral Sclerosis, Huntington Disease
- ER2001Phase 21 trial
ExoRNA Bioscience · Huntington Disease
- MBF-015Phase 21 trial
Medibiofarma S.L. · Huntington Disease
- TominersenRO7234292, RG6042Phase 21 trial
Roche (Genentech) · Huntington Disease
- VO659Phase 21 trial
Vico Therapeutics B. V. · Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.